KMC Speciality Hospitals (India) Ltd.
Snapshot View

59.93 +0.50 ▲0.8%

21 March 2023, 04:01:00 PM
Volume: 22,495

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.kauveryhospital.com
Market Cap 977.37 Cr.
Enterprise Value(EV) 973.23 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 1.45 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 41.25 Trailing Twelve Months Ending 2022-12
Industry PE 46.51 Trailing Twelve Months Ending 2022-12
Book Value / Share 6.51 Trailing Twelve Months Ending 2022-12
Price to Book Value 9.20 Calculated using Price: 59.93
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 16.31 Cr. 163,085,000 Shares
FaceValue 1
Company Profile
KMC Speciality Hospital (I), formerly Seahorse Hospitals Ltd is a renowned hospital situated in Trichy was incorporated in 1999. The hospital boasts of a 24-hour cardiac care with facilities comparable to metropolitan cities like Chennai, Bangalore, Mumbai, etc.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.84%
1 Week
+0.03%
1 Month
+1.49%
3 Month
-7.09%
6 Month
-6.65%
1 Year
+0.98%
2 Year
+171.79%
5 Year
+225.71%
10 Year
+1337.17%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -2.52 1.22 27.24 28.60 24.43 24.78 26.17 22.42 31.61
Return on Capital Employed (%) 2.37 8.53 23.92 34.73 28.63 29.11 33.09 25.85 32.44
Return on Assets (%) -0.88 0.38 10.63 17.14 16.30 16.40 17.24 12.81 17.60

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 10 10 13 24 30 39 51 63 87 100
Non Curr. Liab. 14 12 6 -1 7 5 17 44 44 41
Curr. Liab. 9 9 10 10 12 12 12 13 20 18
Minority Int.
Equity & Liab. 33 31 29 33 49 56 80 120 150 159
Non Curr. Assets 31 28 27 29 41 44 62 93 108 112
Curr. Assets 3 3 3 4 8 13 18 26 42 47
Misc. Exp. not W/O
Total Assets 33 31 29 33 49 56 80 120 150 159

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 32 36 43 55 71 82 96 103 136 147
Other Income 3 0 1 0 0 2 1 3 2 3
Total Income 35 37 44 55 71 84 98 105 138 150
Total Expenditure -30 -31 -35 -42 -56 -66 -75 -80 -99 -110
PBIDT 5 6 9 13 15 18 23 25 40 40
Interest -2 -2 -2 -1 -1 -1 -1 -1 -1 -1
Depreciation -4 -4 -3 -3 -4 -4 -5 -6 -7 -7
Taxation 1 -1 -3 -3 -4 -5 -5 -8 -9
Exceptional Items
PAT 0 0 3 5 7 9 12 13 24 24
Adjusted EPS 0 0 0 0 0 1 1 1 1 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 7 4 5 6 10 12 16 11 26 29
Cash Fr. Inv. -7 -2 -1 -1 -4 -19 -9 -8 -43 -29
Cash Fr. Finan. -3 -1 -5 -5 -5 6 -5 -4 18 -1
Net Change -3 0 0 0 1 -1 1 -1 1 0
Cash & Cash Eqvt 0 0 0 0 1 0 2 1 2 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 20 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulations 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we bring to your kind notice the information received from shareholders through our RTA regarding the loss of share certificates and requesting for issue of duplicate share certificates as per the details attached.
Sat, 18 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulations 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we bring to your kind notice the information received from shareholders through our RTA regarding the loss of share certificates and requesting for issue of duplicate share certificates as per the details attached.
Thu, 16 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulations 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we bring to your kind notice the information received from shareholders through our RTA regarding the loss of share certificates and requesting for issue of duplicate share certificates as per the details attached.

Technical Scans View Details >>

Mon, 20 Mar 2023
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
50 SMA Crossing 200 SMA From Above 50 SMA Crossing 200 SMA From Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 230,636.07 956.20 -0.5%
Divi's Laboratories Ltd. 74,303.33 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. 73,967.90 4,419.30 -0.5%
Cipla Ltd. 70,000.14 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,905.77 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,514.78 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,165.73 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.76 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.06 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.25 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 26.53 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.95 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.90 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.34 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.17 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.35 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 3.08 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.07 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.79 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On KMC Speciality Hospitals (India) Ltd.

What is KMC Speciality Hosp share price?

Can I buy KMC Speciality Hosp shares now?

What is the Market Cap of KMC Speciality Hosp?

What are the key metrics to analyse KMC Speciality Hosp?

What is the 52 Week High and Low of KMC Speciality Hosp?

What is the trend of KMC Speciality Hosp share price?